Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study
about
Vaccines for preventing pneumococcal infection in adultsInsights on common vaccinations in HIV-infection: efficacy and safetyHumoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infectionPredictors of mortality in HIV-associated hospitalizations in Portugal: a hierarchical survival model.Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007.HIV-associated opportunistic pneumoniasThe effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review.Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control studyPredictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).Quantitative and Qualitative Antibody Responses to Immunization With the Pneumococcal Polysaccharide Vaccine in HIV-Infected Patients After Initiation of Antiretroviral Treatment: Results From a Randomized Clinical Trial.Association of COPD With Risk for Pulmonary Infections Requiring Hospitalization in HIV-Infected Veterans.A comparative public health and budget impact analysis of pneumococcal vaccines: The French caseHIV/AIDS, comorbidity, and alcohol: can we make a difference?Comparing clinical outcomes in HIV-infected and uninfected older men hospitalized with community-acquired pneumoniaMeningitis in HIV-positive patients in sub-Saharan Africa: a review.HIV-related pneumococcal disease prevention in adults.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.23-Valent Pneumococcal Polysaccharide Vaccine Uptake in the United States Air Force HIV Program.Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.Low bone mineral density in emphysema: epiphenomenon of a wasting phenotype?Risk and incidence of pulmonary diseases among HIV-infected patients in the era of combination antiretroviral therapy.A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in GermanyCost–effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in GermanyPrevention of bacterial pneumonia in HIV infection: focus on smoking cessation
P2860
Q24201474-F56A94B8-062D-4556-93EE-87EE2B28DF8DQ26770665-C98DF7C1-7BD9-491F-8E93-7988D3078CF3Q27023322-4A5EBAF3-5013-48AA-AA6F-282CA30E16C7Q33486116-45408B40-2E79-4AB8-9AFD-1BEB1F4B76EFQ33529099-E881347D-F74D-41D5-9BAF-5869C5D743CEQ33715315-D4F76A15-3B19-4010-B3BB-3685D4EE3C41Q33741026-BDA3792B-6475-48D4-8F73-429B9DB320B6Q34606647-9301A136-1987-40FF-8254-D09100D2B927Q34625248-4DEBBAEA-6BBC-49A7-AE4A-0A318C2344ABQ35753485-16EB34B7-16A3-4991-B548-5FF5EB0B3FC9Q36167106-B39A1EEE-DD5F-4F0D-8BCC-A22BDFE5C35BQ36255763-ED387ABB-4D87-4B75-8754-5E48AAC2F9B8Q37011927-1F005640-0DC2-4FB5-82EF-3FF85ABC215AQ37240889-A8C5F68E-0C94-40AE-8E2E-9C1BFB94DD22Q38259519-0FA86298-E86D-43B2-90BE-E4E7DFCE026EQ38947827-D1982B51-B0F6-413F-811D-8CA5ED9ED579Q40560650-EEF04AD5-33F2-47D9-9C4A-CEEE17F1969FQ40663139-B30B25EC-66C5-4B61-A79B-8D2AAB673EC8Q41753512-E5263624-0A77-42A3-8235-D9825317CDBAQ41755202-A20F3487-7ADC-4D4D-A56D-B80D3F14328EQ42343376-01BCA307-5111-4005-B003-532332A8337DQ42343377-BD38E644-6C99-4D9A-82FF-3BAA0D18FFDFQ58286118-87ACF238-0AFD-402E-BFF3-B61966C6C967Q58286129-7000204D-9993-4725-A670-A2C30492FDC9Q58812637-9F233383-8558-4B41-AE8E-752FB0849B12
P2860
Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Impact of pneumococcal vaccina ...... rans Aging Cohort 5-Site Study
@en
type
label
Impact of pneumococcal vaccina ...... rans Aging Cohort 5-Site Study
@en
prefLabel
Impact of pneumococcal vaccina ...... rans Aging Cohort 5-Site Study
@en
P2093
P2860
P50
P356
P1476
Impact of pneumococcal vaccina ...... rans Aging Cohort 5-Site Study
@en
P2093
Amy C Justice
David Rimland
Maria C Rodriguez-Barradas
Michael S Simberkoff
Sheldon Brown
P2860
P304
P356
10.1086/529201
P407
P577
2008-04-01T00:00:00Z